NHS National Pharmaceuticals Transition 2021_3
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02b7a632014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
59
32 SME
Lots
7
59 awarded
Published
04 Nov 2021
Other contracts from The NHS Commissioning Board (operating under the name of NHS England)· 10
Most recent notices published by the same contracting authority.
Other contracts awarded to Glenmark Pharmaceuticals Europe Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines | contract | — | 06 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |
| NHS National Generic Pharmaceuticals Wave 15b | contract | — | 04 Aug 2025 |
| NP35925 Cardiovascular & Respiratory Medicines | contract | — | 06 May 2025 |